Drug intelligence / Profile preview

Collatamp G (Innocoll)

Development stage
Unknown
Lead developer
Innocoll
Modality
Small Molecules
Administration
Topical
01

Overview

Collatamp G is a surgically implantable, biodegradable combination product developed by Innocoll for the prevention of surgical wound infections. It consists of a purified bovine collagen matrix impregnated with gentamicin sulfate, an aminoglycoside antibiotic. The product is designed to be placed directly into the surgical site before closure, where it provides high local bactericidal concentrations of gentamicin while maintaining low systemic levels, thereby reducing the risk of systemic toxicities such as nephrotoxicity. The collagen matrix acts as a scaffold that is gradually resorbed by the body over several weeks. While approved in over 50 countries for various surgical applications including cardiac and orthopedic procedures, a major Phase 3 trial in the United States for colorectal surgery failed to demonstrate efficacy in reducing surgical site infections, leading to a paradoxical increase in infection rates in some study populations.

Brand names
Collatamp GCollatampSeptocollGentaColGaramycin Sponge
Other names
gentamicin-collagen spongegentamicin-collagen implantgentamicin-collagen matrix
02

Targets

Bacterial Ribosome

Beyond the preview

Go deeper on Collatamp G (Innocoll).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collatamp G (Innocoll).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call